GlaxoSmithKline S.A.E (EGX:BIOC)
Egypt
· Delayed Price · Currency is EGP 59.28
-1.75 (-2.87%)
At close: Mar 1, 2026
58.97% (1Y)
| Market Cap | 4.95B |
| Revenue (ttm) | 3.74B |
| Net Income (ttm) | 98.36M |
| Shares Out | 83.51M |
| EPS (ttm) | 1.17 |
| PE Ratio | 50.60 |
| Forward PE | n/a |
| Dividend | 1.00 (1.64%) |
| Ex-Dividend Date | Jan 12, 2026 |
| Volume | 32,105 |
| Average Volume | 60,270 |
| Open | 61.03 |
| Previous Close | 61.03 |
| Day's Range | 55.10 - 61.00 |
| 52-Week Range | 32.66 - 81.50 |
| Beta | 0.88 |
| RSI | 40.24 |
| Earnings Date | Mar 5, 2026 |